Home/Filings/4/0001209191-18-030129
4//SEC Filing

Session R.A. II 4

Accession 0001209191-18-030129

CIK 0001652923other

Filed

May 14, 8:00 PM ET

Accepted

May 15, 12:39 PM ET

Size

12.5 KB

Accession

0001209191-18-030129

Insider Transaction Report

Form 4
Period: 2018-05-15
Session R.A. II
Sr. VP, Corp Strategy
Transactions
  • Disposition to Issuer

    Common Stock

    2018-05-151,6670 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-05-1535,9500 total
    Exercise: $79.75Exp: 2027-03-20Common Stock (35,950 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-05-151,2820 total
    Exercise: $77.24Exp: 2027-05-10Common Stock (1,282 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-05-156,5720 total
    Exercise: $133.80Exp: 2028-03-13Common Stock (6,572 underlying)
Footnotes (3)
  • [F1]On April 6, 2018, the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Novartis AG, a company organized under the laws of Switzerland ("Parent"), and Novartis AM Merger Corporation, a Delaware corporation and an indirect wholly-owned subsidiary of the Parent ("Purchaser"). Pursuant to the terms of the Merger Agreement and the Offer (as defined in the Merger Agreement), each share of the Issuer's common stock (the "Common Stock") held by the Reporting Person was acquired, subject to adjustment, at a purchase price of $218.00 per share (the "Offer Price") in cash.
  • [F2]Represents 1,667 shares underlying Restricted Stock Units (the "RSUs"). Pursuant to the Merger Agreement, each outstanding RSU was canceled in exchange for a lump sum cash payment equal to (i) the Offer Price multiplied by (ii) the number of shares of Common Stock underlying the RSU.
  • [F3]Pursuant to the Merger Agreement, each outstanding stock option was canceled in exchange for a lump sum cash payment equal the excess of (A) the Offer Price minus (B) the Exercise Price, multiplied by the number of shares of Common Stock underlying the option.

Issuer

AveXis, Inc.

CIK 0001652923

Entity typeother

Related Parties

1
  • filerCIK 0001701846

Filing Metadata

Form type
4
Filed
May 14, 8:00 PM ET
Accepted
May 15, 12:39 PM ET
Size
12.5 KB